SCHEMBL7466480

SCHEMBL7466480

CCC(=O)NC1(c2ccccc2Cl)C(=O)N(S(=O)(=O)c2ccc(OC)cc2OC)c2ccc(Cl)cc21

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 20/20 0.52
OXTR P30559 7/20 0.52
AVPR1A P37288 7/20 0.52
AVPR2 P30518 3/20 0.52
GPR65 Q8IYL9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471178 0.91 AVPR1B (0.54) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7468544 0.91 AVPR1B (0.54) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7467475 0.90 AVPR1B (0.52) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7463686 0.89 AVPR1B (0.57) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL5674427 0.88 AVPR1B (0.51) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7470712 0.86 AVPR1B (0.52) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7464945 0.83 AVPR1B (0.45) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7471418 0.83 AVPR1B (0.43) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL5678532 0.82 AVPR1B (0.55) AVPR1BOXTRAVPR1AAVPR2GPR65
SCHEMBL7469533 0.82 AVPR1B (0.43) AVPR1BOXTRAVPR1AAVPR2GPR65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0687251-B1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI SYNTHELABO (FR) 2002-02-27 EP disclosed
US-5773612-A VASOPRESSIN OR OXYTOCIN RECEPTORS SANOFI (FR) 1998-06-30 US disclosed
US-5594023-A 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present SANOFI (FR) 1997-01-14 US disclosed